HomeCURX • NASDAQ
add
Curanex Pharmaceuticals Inc
Previous close
$0.46
Day range
$0.48 - $0.51
Year range
$0.38 - $9.18
Market cap
13.81M USD
Avg Volume
478.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 273.85K | 193.53% |
Net income | -954.06K | -946.51% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.83M | 2,286.43% |
Total assets | 14.48M | 2,140.78% |
Total liabilities | 185.96K | 3,220.62% |
Total equity | 14.29M | — |
Shares outstanding | 28.34M | — |
Price to book | 0.93 | — |
Return on assets | -31.16% | — |
Return on capital | -31.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -954.06K | -946.51% |
Cash from operations | -9.19M | -6,970.04% |
Cash from investing | — | — |
Cash from financing | 14.91M | — |
Net change in cash | 5.72M | 4,503.19% |
Free cash flow | -8.45M | -9,465.31% |
About
Founded
1996
Website
